Medpace Holdings, Inc. MEDP
663.49 USD +15.35 (+2.37%)
At closeNov 3, 2026, 4:00 PM EST
663.49 0.00 0.00%
After hours · Nov 3, 4:00 PM ET
648.26 Day range 673.25
373.00 52-week range 693.97
- YTD
- +18.13%
- 1 year
- +11.69%
Analyst view
Consensus: hold
Hold
Price target (mean) 651.31 -1.8% downside
Now 663.49
- Target (low)
- 370.00
- Target (mean)
- 651.31
- Target (high)
- 730.00
Ratings (0m) 14 2 buy · 11 hold · 1 sell
- Strong buy1
- Buy1
- Hold11
- Sell1
- Strong sell0
Recommendation trend
- This month 14
- 1 month ago 14
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 4.88 | 4.77 – 5.06 | 4.67 | +4.4% | 718.40M | +1.4% | 9 |
| Next quarter | 4.66 | 4.50 – 4.91 | 4.28 | +8.8% | 726.89M | +2.9% | 7 |
| Current year | 18.36 | 18.11 – 18.92 | 15.28 | +20.2% | 2.85B | +12.6% | 11 |
| Next year | 19.85 | 19.30 – 20.35 | 18.36 | +8.1% | 3.02B | +6.0% | 11 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 26, 2026 | BMO Capital | Maintained | Market Perform | Market Perform |
| Oct 23, 2026 | UBS | Maintained | Neutral | Neutral |
| Oct 23, 2026 | Truist Securities | Maintained | Hold | Hold |
| Oct 23, 2026 | Barclays | Maintained | Equal-Weight | Equal-Weight |
| Oct 23, 2026 | TD Cowen | Maintained | Hold | Hold |
| Oct 7, 2026 | Mizuho | Maintained | Outperform | Outperform |
| Oct 7, 2026 | Barclays | Maintained | Equal-Weight | Equal-Weight |
| Sep 30, 2026 | UBS | Upgrade | Sell | Neutral |
| Jul 24, 2026 | Mizuho | Maintained | Outperform | Outperform |
| Jul 24, 2026 | BMO Capital | Maintained | Market Perform | Market Perform |
| Jul 24, 2026 | Truist Securities | Maintained | Hold | Hold |
| Jul 24, 2026 | TD Cowen | Maintained | Hold | Hold |
| Jul 24, 2026 | RBC Capital | Maintained | Outperform | Outperform |
| Jul 24, 2026 | Baird | Maintained | Neutral | Neutral |
| Jul 13, 2026 | Mizuho | Maintained | Outperform | Outperform |
| Jul 8, 2026 | Baird | Downgrade | Outperform | Neutral |
| Jul 7, 2026 | Jefferies | Downgrade | Buy | Hold |
| Apr 24, 2026 | Barclays | Maintained | Equal-Weight | Equal-Weight |
| Apr 24, 2026 | BMO Capital | Maintained | Market Perform | Market Perform |
| Apr 24, 2026 | RBC Capital | Maintained | Outperform | Outperform |
| Apr 24, 2026 | Baird | Maintained | Outperform | Outperform |
| Mar 6, 2026 | Barclays | Upgrade | Underweight | Equal-Weight |
| Mar 3, 2026 | RBC Capital | Initiated | — | Outperform |
| Feb 18, 2026 | TD Cowen | Upgrade | Sell | Hold |
| Feb 13, 2026 | Jefferies | Upgrade | Hold | Buy |
| Feb 11, 2026 | Barclays | Maintained | Underweight | Underweight |
| Feb 11, 2026 | Truist Securities | Maintained | Hold | Hold |
| Feb 11, 2026 | Leerink Partners | Maintained | Market Perform | Market Perform |
| Dec 15, 2025 | Barclays | Maintained | Underweight | Underweight |
| Nov 13, 2025 | BMO Capital | Initiated | — | Market Perform |